Amar Rewari, M.D., M.B.A

Education:

• B.A.               Temple University
• M.B.A             Yale University School of Management
• M.D.              Yale University School of Medicine       
• Residency      UMDNJ - Robert Wood Johnson Medical School

Academic Appointments:

• Resident Physician

Professional Services:

• 2009 – Present   Commission on Radiation Oncology (ACR)
• 2009 – Present   Economic Standing Committee (ACRO)
• 2009 – Present   Corporate Relations Committee (ASTRO)
• 2009 – Present   Payment Systems Committee (ASTRO)
• 2009 – Present   Cancer Committee ( Robert Wood Johnson University Hospital )
• 2009 – Present   Resident Council, GME Committee (University of Medicine & Dentistry of New Jersey )

Honors/Certificates:

• 2009   Travel Grant, ACRO 2010 Annual Meeting, Orlando , FL
• 2009   Travel Grant, ASTRO Advocacy Day 2009, Washington , D.C.
• 2009   NCCN Fellows Recognition Program, NCCN Annual Meeting, Hollywood , FL
• 2008-2009   Elected by peers to serve as GME resident representative for past two years
• 2004   Frederick Frank Fellowship for International Leadership Potential
• 2003   Completed clinical electives in Mumbai , India and Sydney , Australia
• 2001   Phi Beta Kappa
• 2001   Summa Cum Laude
• 2001   Dean's List every semester
• 2000   Fulbright Finalist
• 1999   Studied international healthcare economics and financing at the University of Copenhagen

Selected Peer-Reviewed Publications for the recent 5 years:

1. Rewari A , Lu H, Yang Q, Shen Z, Haffty BG. BCCIP: A Novel Marker for Radiotherapy Benefit in Patients with Laryngeal Cancer. Radiotherapy and Oncology . 2009 Feb; 183-8.
2. Rewari A, Haffty BG, Wilson LD, Son YH, Joe JK, Ross DA, Papac RJ, Sasaki CT, Fischer JJ. Postoperative Concurrent Chemoradiotherapy with Mitomycin in Advanced Squamous Cell Carcinoma of the Head and Neck: Results from Three Prospective Randomized Trials. The Cancer Journal . 2006 Mar-Apr; 123-9.
3. Chang W, Rewari A , Centrella M, McCarthy TL. Fos-related antigen 2 controls protein kinase A-induced CCAAT/ enhancer-binding protein beta expression in osteoblasts. The Journal of Biological Chemistry . 2004 Oct; 42438-44.

Presentations at Scientific Meetings:

1. 2009    Poster Presentation. Prognostic Value of p53 Expression in Patients Treated with Breast Conserving Therapy. American Society for Radiation Oncology (ASTRO) , Chicago , IL .
2. 2007    Oral Presentation. BCCIP: A Novel Marker for Radotherapy Benefit in Patients with Laryngeal Cancer. American Society for Clinical Oncology (ASCO), Chicago , IL .
3. 2005    Oral Presentation. Postoperative Concurrent Chemoradiotherapy with Mitomycin in Advanced Squamous Cell Carcinoma of the Head and Neck: Results from Three Prospective Randomized Trials. American Radium Society (ARS), Barcelona , Spain .